The novel approach of the medication represents a major development in the management of the condition. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide460401.howeweb.com/42652936/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment